Search details
1.
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features.
Proc Natl Acad Sci U S A
; 121(4): e2308942121, 2024 Jan 23.
Article
in English
| MEDLINE | ID: mdl-38241441
2.
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.
PLoS Pathog
; 19(6): e1011469, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37384759
3.
HIV Diagnostics and Vaccines: It Takes Two to Tango.
J Infect Dis
; 2024 Mar 07.
Article
in English
| MEDLINE | ID: mdl-38451247
4.
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
N Engl J Med
; 384(12): 1089-1100, 2021 03 25.
Article
in English
| MEDLINE | ID: mdl-33761206
5.
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
N Engl J Med
; 384(11): 1003-1014, 2021 03 18.
Article
in English
| MEDLINE | ID: mdl-33730454
6.
Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk.
J Infect Dis
; 226(2): 246-257, 2022 08 24.
Article
in English
| MEDLINE | ID: mdl-35758878
7.
High Asymptomatic Carriage With the Omicron Variant in South Africa.
Clin Infect Dis
; 75(1): e289-e292, 2022 08 24.
Article
in English
| MEDLINE | ID: mdl-35353885
8.
Development of flow cytometry-based assays to assess the ability of antibodies to bind to SARS-CoV-2-infected and spike-transfected cells and mediate NK cell degranulation.
Cytometry A
; 101(6): 483-496, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35301794
9.
Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period.
J Infect Dis
; 219(11): 1755-1765, 2019 05 05.
Article
in English
| MEDLINE | ID: mdl-30615119
10.
Functions of IL-4 and Control of Its Expression.
Crit Rev Immunol
; 37(2-6): 181-212, 2017.
Article
in English
| MEDLINE | ID: mdl-29773020
11.
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial.
J Infect Dis
; 215(9): 1376-1385, 2017 05 01.
Article
in English
| MEDLINE | ID: mdl-28199679
12.
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
PLoS Med
; 14(11): e1002435, 2017 Nov.
Article
in English
| MEDLINE | ID: mdl-29136037
13.
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.
J Infect Dis
; 213(4): 541-50, 2016 Feb 15.
Article
in English
| MEDLINE | ID: mdl-26475930
14.
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.
N Engl J Med
; 369(22): 2083-92, 2013 Nov 28.
Article
in English
| MEDLINE | ID: mdl-24099601
15.
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.
J Infect Dis
; 210(1): 99-110, 2014 Jul 01.
Article
in English
| MEDLINE | ID: mdl-24403557
16.
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery.
J Infect Dis
; 208(5): 818-29, 2013 Sep 01.
Article
in English
| MEDLINE | ID: mdl-23840043
17.
Preexisting adenovirus seropositivity is not associated with increased HIV-1 acquisition in three HIV-1 vaccine efficacy trials.
J Infect Dis
; 205(12): 1806-10, 2012 Jun 15.
Article
in English
| MEDLINE | ID: mdl-22492863
18.
Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants.
PLOS Glob Public Health
; 3(6): e0002037, 2023.
Article
in English
| MEDLINE | ID: mdl-37289667
19.
Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01.
Nat Commun
; 14(1): 7813, 2023 Nov 28.
Article
in English
| MEDLINE | ID: mdl-38016958
20.
Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition.
EBioMedicine
; 93: 104590, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37300931